Encapsulation of conjugated linoleic acid and ruminant trans fatty acids to study the prevention of metabolic syndrome—a review
Nutrition Reviews · 2024
DOI: 10.1093/nutrit/nuad047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrition Reviews, 2024. Verfasst von Farzad Mohammadi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Kinesiology, Faculty of Medicine, Université Laval, Québec City, Québec, Canada. Hauptthemen laut MEDLINE: Trans Fatty Acids, Linoleic Acids, Conjugated, Metabolic Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: Natural Sciences and Engineering Research Council of Canada, Faculty of Pharmacy of Université Laval.
Abstract (Originalsprache)
Studies have reported the potential benefits of consuming conjugated linoleic acid (CLA) and ruminant trans fatty acids (R-TFAs) in reducing the risk factors of metabolic syndrome (MetS). In addition, encapsulation of CLA and R-TFAs may improve their oral delivery and further decrease the risk factors of MetS. The objectives of this review were (1) to discuss the advantages of encapsulation; (2) to compare the materials and techniques used for encapsulating CLA and R-TFAs; and (3) to review the effects of encapsulated vs non-encapsulated CLA and R-TFAs on MetS risk factors. Examination of papers citing micro- and nano-encapsulation methods used in food sciences, as well as the effects of encapsulated vs non-encapsulated CLA and R-TFAs, was conducted using the PubMed database. A total of 84 papers were examined; of these, 18 studies were selected that contained information on the effects of encapsulated CLA and R-TFAs. The 18 studies that described encapsulation of CLA or R-TFAs indicated that micro- or nano-encapsulation processes stabilized CLA and prevented oxidation. CLA was mainly encapsulated using carbohydrates or proteins. So far, oil-in-water emulsification followed by spray-drying were the frequently used techniques for encapsulation of CLA. Further, 4 studies investigated the effects of encapsulated CLA on MetS risk factors compared with non-encapsulated CLA. A limited number of studies investigated the encapsulation of R-TFAs. The effects of encapsulated CLA or R-TFAs on the risk factors for MetS remain understudied; thus, additional studies comparing the effects of encapsulated and non-encapsulated CLA or R-TFAs are needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Kinesiology, Faculty of Medicine, Université Laval, Québec City, Québec, Canada.
- Endocrinology and Nephrology Unit, CHU de Québec-Université Laval Research Center, Québec City, Québec, Canada.
- Faculty of Pharmacy, Pavillon Ferdinand-Vandry, Université Laval, Québec City, Québec, Canada.
ORCID-Profile: Iwona Rudkowska
Förderung
- Natural Sciences and Engineering Research Council of Canada
- Faculty of Pharmacy of Université Laval
Zitieren
APA
Mohammadi, F., Dikpati, A., Bertrand, N., & Rudkowska, I. (2024). Encapsulation of conjugated linoleic acid and ruminant trans fatty acids to study the prevention of metabolic syndrome—a review. Nutrition Reviews. https://doi.org/10.1093/nutrit/nuad047
Vancouver
Mohammadi F, Dikpati A, Bertrand N, Rudkowska I. Encapsulation of conjugated linoleic acid and ruminant trans fatty acids to study the prevention of metabolic syndrome—a review. Nutrition Reviews. 2024. doi:10.1093/nutrit/nuad047
BibTeX
@article{Mohammadi2024,
author = {Mohammadi, Farzad and Dikpati, Amrita and Bertrand, Nicolas and Rudkowska, Iwona},
title = {Encapsulation of conjugated linoleic acid and ruminant trans fatty acids to study the prevention of metabolic syndrome—a review},
journal = {Nutrition Reviews},
year = {2024},
doi = {10.1093/nutrit/nuad047}
}
EUVIMED